CAPriCORN's Response to COVID-19
The Natural Experiments for Translation in Diabetes (NEXT-D) Study examines how the Affordable Care Act expansion of Medicaid affects diabetes diagnosis, treatment, and outcomes among the newly enrolled. The study compares the differences that arise between some states expanding Medicaid and others choosing not to do so. Data is being combined with detailed, longitudinal electronic health record (EHR) data for a large population of 9 million in four expansion and five non-expansion states.
This cooperative agreement is jointly funded by the Centers for Disease Control and Prevention (CDC) and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The CDC Funding Opportunity Announcement (FOA) Number is RFA- DP10-002, entitled, “Natural Experiments and Effectiveness Studies to Identify the Best Policy and System Level Practices to Prevent Diabetes and Its Complications.”
The NEXT-D project created the study population utilizing the CAPriCORN data repository. The study population’s individual addresses will then be geocoded to create the control group for analysis.
Abel Kho, MD, MS, FACMI
References in this website to any specific commercial products, process, service, manufacturer, or company does not constitute its endorsement or recommendation by the members of the Chicago Area Patient-Centered Outcomes Research Network (CAPriCORN).